Hepion Pharmaceuticals Inc (HEPA)

US · Healthcare · Biotechnology

$0.06-11.97%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-1.2M

EPS

$-0.09

EPS estimate

$0.00

Market cap

$6.4M

Forward P/E

0.0

P/B

41.86

Book value

$-0.01

EPS (TTM)

$-0.03

52-week high

$0.11

52-week low

$0.03

50-day MA

$0.07

200-day MA

$0.06

Beta

1.76

Analysts rate Hepion Pharmaceuticals Inc a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $30.00.

Insiders

41.29%

Fund	Stake
XTX Topco Ltd	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Hepion Pharmaceuticals Inc — free to start.

Data updated 2026-09-18.